News12 NJ – Appropriation from the State of New Jersey for Pediatric Cancer will Help Advance Research and Treatment – July 28, 2021
$10 million dollars from the New Jersey governor's state budget is going to establish the pediatric cancer center at the Rutgers Cancer Institute of New Jersey. The funding is championed by Grace Eline, a 12 year-old brain cancer survivor.
The Pulse: NPR – How a clinical trial cured cancer — in some cases – July 16, 2021
Christian S. Hinrichs, MD, chief of the Section of Cancer Immunotherapy and Co-Director of the Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, has been featured on WHYY’S The Pulse, a weekly health and science podcast, to discuss cancer research and his own experience with cancer.
One on One with Steve Adubato – The Impact of COVID on Cancer Care – July 3, 2021
Steven K. Libutti, MD, FACS, director of Rutgers Cancer Institute of New Jersey and senior vice president oncology services, RWJBarnabas Health, appeared on "One on One with Steve Adubato" along with Christopher Paladino, president, New Brunswick Development Corporation, to discuss the new Jack and Sheryl Morris Cancer Center.
WMBC – Today starts a new chapter in the fight to eradicate cancer – June 24, 2021
WMBC reports on the ceremonial groundbreaking of the new Jack and Sheryl Morris Cancer Center, New Jersey's first free-standing cancer hospital and a collaboration between RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state's only NCI-designated Comprehensive Cancer Center.
CBS New York – COVID Impact: Doctors Say Delayed Care For Other Conditions No Longer An Issue, Urge Patients To Book Appointments – March 4, 2021
Dr. Andy Evens spoke with CBS New York about how the pandemic has impacted cancer screenings.
$10 million dollars from the New Jersey governor's state budget is going to establish the pediatric cancer center at the Rutgers Cancer Institute of New Jersey. The funding is championed by Grace Eline, a 12 year-old brain cancer survivor.
The Pulse: NPR – How a clinical trial cured cancer — in some cases – July 16, 2021
Christian S. Hinrichs, MD, chief of the Section of Cancer Immunotherapy and Co-Director of the Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, has been featured on WHYY’S The Pulse, a weekly health and science podcast, to discuss cancer research and his own experience with cancer.
One on One with Steve Adubato – The Impact of COVID on Cancer Care – July 3, 2021
Steven K. Libutti, MD, FACS, director of Rutgers Cancer Institute of New Jersey and senior vice president oncology services, RWJBarnabas Health, appeared on "One on One with Steve Adubato" along with Christopher Paladino, president, New Brunswick Development Corporation, to discuss the new Jack and Sheryl Morris Cancer Center.
WMBC – Today starts a new chapter in the fight to eradicate cancer – June 24, 2021
WMBC reports on the ceremonial groundbreaking of the new Jack and Sheryl Morris Cancer Center, New Jersey's first free-standing cancer hospital and a collaboration between RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state's only NCI-designated Comprehensive Cancer Center.
CBS New York – COVID Impact: Doctors Say Delayed Care For Other Conditions No Longer An Issue, Urge Patients To Book Appointments – March 4, 2021
Dr. Andy Evens spoke with CBS New York about how the pandemic has impacted cancer screenings.
BBC Radio – 5 Live Science Podcast – December 13, 2020
Renata Pasqualini, PhD has been featured on BBC’s 5 Life Science podcast to discuss a recent discovery of a new method of delivering medicines safely and effectively to the lungs. Interview begins at 7:00.
WBGO Radio – Rutgers Cancer Research Education Program Gets Million-Dollar Grant – October 13, 2020
Dr. Chaudhary spoke with WBGO Radio about the grant from the National Cancer Institute and the RUYES program.
NJ News Network – COVID-19: How Breast Cancer Screenings Are Being Impacted – October 7, 2020
Michele Blackwood, MD, FACS, spoke with NJ News Network about how the pandemic has impacted breast cancer screenings, and encourages patients not to continue to postpone appointments.
News 12 NJ – Doctors urge women not to skip breast cancer screenings during pandemic – October 6, 2020
Deborah Toppmeyer, MD, spoke with News 12 New Jersey about the importance of screening even during the COVID-19 pandemic.
OncLive – Companion Diagnostic, Targeted Therapy Approvals Rise in Tandem – August 23, 2020
Shridar Ganesan, MD, PhD, associate director for Translational Science and section chief of Molecular Oncology at the Rutgers Cancer Institute of New Jersey in New Brunswick, speaks to OncLive.
News 12 New Jersey – Health professionals: Don’t put off health screenings because of the pandemic – July 13, 2020
Health professionals are reminding people that they do not have to delay potentially life-saving health screenings during the pandemic.
Medicine Matters: Oncology – Researcher comment: The KEYNOTE-799 trial – June 4, 2020
Salma Jabbour, MD, discusses the KEYNOTE-799 study of pembrolizumab plus concurrent chemoradiotherapy in nonresectable stage III non-small-cell lung cancer patients.
MDAdvantage – 12 Rutgers Rallies: Fighting Coronavirus with Collaboration – May 12, 2020
Steven K. Libutti, MD, Director of the Rutgers Cancer Institute of New Jersey and Senior Vice President of Oncology Services at RWJBarnabas Health, explains to Steve Adubato, PhD, how the pandemic has ushered in unprecedented changes.
MD/alert – Pembrolizumab with Simultaneous Chemoradiotherapy Proves Safe and Effective – April 16, 2020
Salma Jabbour, MD, spoke with MD/alert about the results of her Phase I study recently published in JAMA on the combination of Pembrolizumab and chemoradiotherapy for treatment of lung cancer.
NJTV News – Governor reveals kidney tumor, says prognosis is ‘very good’ – February 24, 2020
Eric A. Singer, MD, MA, MS, FACS, Director, Kidney Cancer Program at Rutgers Cancer Institute of New Jersey spoke to NJTV News about the detection and treatment of kidney tumors, in light of the Governor's announcement of his diagnosis.
One on One with Steve Adubato – Using Collaborative Care to Treat Patients with Cancer – February 4, 2020
Steven K. Libutti, MD, FACS, Senior Vice President, Oncology Services, RWJBarnabas Health, and Director, Rutgers Cancer Institute of New Jersey, and Barry Ostrowsky, President & CEO, RWJBarnabas Health, joined Steve Adubato to discuss the new Cancer Pavilion and the benefits for patients provided by collaborative cancer care.
News 12 New Jersey – American Cancer Society: Death rates have biggest drop in single year – January 8, 2020
A new American Cancer Society report shows a 2.2 percent drop in U.S. cancer deaths between 2016 and 2017 – the largest-ever single-year decrease. Rutgers Cancer Institute Drs. Janice Mehnert and Salma Jabbour weigh in in this News 12 segment.
Renata Pasqualini, PhD has been featured on BBC’s 5 Life Science podcast to discuss a recent discovery of a new method of delivering medicines safely and effectively to the lungs. Interview begins at 7:00.
WBGO Radio – Rutgers Cancer Research Education Program Gets Million-Dollar Grant – October 13, 2020
Dr. Chaudhary spoke with WBGO Radio about the grant from the National Cancer Institute and the RUYES program.
NJ News Network – COVID-19: How Breast Cancer Screenings Are Being Impacted – October 7, 2020
Michele Blackwood, MD, FACS, spoke with NJ News Network about how the pandemic has impacted breast cancer screenings, and encourages patients not to continue to postpone appointments.
News 12 NJ – Doctors urge women not to skip breast cancer screenings during pandemic – October 6, 2020
Deborah Toppmeyer, MD, spoke with News 12 New Jersey about the importance of screening even during the COVID-19 pandemic.
OncLive – Companion Diagnostic, Targeted Therapy Approvals Rise in Tandem – August 23, 2020
Shridar Ganesan, MD, PhD, associate director for Translational Science and section chief of Molecular Oncology at the Rutgers Cancer Institute of New Jersey in New Brunswick, speaks to OncLive.
News 12 New Jersey – Health professionals: Don’t put off health screenings because of the pandemic – July 13, 2020
Health professionals are reminding people that they do not have to delay potentially life-saving health screenings during the pandemic.
Medicine Matters: Oncology – Researcher comment: The KEYNOTE-799 trial – June 4, 2020
Salma Jabbour, MD, discusses the KEYNOTE-799 study of pembrolizumab plus concurrent chemoradiotherapy in nonresectable stage III non-small-cell lung cancer patients.
MDAdvantage – 12 Rutgers Rallies: Fighting Coronavirus with Collaboration – May 12, 2020
Steven K. Libutti, MD, Director of the Rutgers Cancer Institute of New Jersey and Senior Vice President of Oncology Services at RWJBarnabas Health, explains to Steve Adubato, PhD, how the pandemic has ushered in unprecedented changes.
MD/alert – Pembrolizumab with Simultaneous Chemoradiotherapy Proves Safe and Effective – April 16, 2020
Salma Jabbour, MD, spoke with MD/alert about the results of her Phase I study recently published in JAMA on the combination of Pembrolizumab and chemoradiotherapy for treatment of lung cancer.
NJTV News – Governor reveals kidney tumor, says prognosis is ‘very good’ – February 24, 2020
Eric A. Singer, MD, MA, MS, FACS, Director, Kidney Cancer Program at Rutgers Cancer Institute of New Jersey spoke to NJTV News about the detection and treatment of kidney tumors, in light of the Governor's announcement of his diagnosis.
One on One with Steve Adubato – Using Collaborative Care to Treat Patients with Cancer – February 4, 2020
Steven K. Libutti, MD, FACS, Senior Vice President, Oncology Services, RWJBarnabas Health, and Director, Rutgers Cancer Institute of New Jersey, and Barry Ostrowsky, President & CEO, RWJBarnabas Health, joined Steve Adubato to discuss the new Cancer Pavilion and the benefits for patients provided by collaborative cancer care.
News 12 New Jersey – American Cancer Society: Death rates have biggest drop in single year – January 8, 2020
A new American Cancer Society report shows a 2.2 percent drop in U.S. cancer deaths between 2016 and 2017 – the largest-ever single-year decrease. Rutgers Cancer Institute Drs. Janice Mehnert and Salma Jabbour weigh in in this News 12 segment.
MD/alert – Breaking Study Finds Optimal Screening Interval for Breast Cancer – December 11, 2019
M. Michele Blackwood, MD, discusses recent study results concerning the ideal frequency for breast cancer screenings.
Lymphoma Australia – HoLISTIC Hodgkin Lymphoma International Study – December 7, 2019
Andrew Evens, DO, MSc, FACP, Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey, Medical Director, RWJBarnabas Health, New Brunswick, spoke with Donna Gairns, National Lymphoma Nurse Manager from Lymphoma Australia at ASH 2019, Orlando, Florida.
OncologyTube – Management of Small Renal Masses – December 5, 2019
Eric A. Singer, MD, MA, MS, FACS discusses the management of small renal masses at the Kidney Cancer Association's 18th International Kidney Cancer Symposium in Miami, Florida.
Targeted Oncology – Brentuximab Vedotin Adds Benefit to A+AVD Therapy in cHL – December 3, 2019
Andrew M. Evens, DO, MSc, director of the Lymphoma Program and associate director for Clinical Services at the Rutgers Cancer Institute of New Jersey, discusses the significance of the results from the phase III ECHELON-1 trial in which patients with stage III/IV classical Hodgkin lymphoma (cHL) were treated with the combination of brentuximab vedotin (Adcetris) plus doxorubicin, vinblastine, and dacarbazine (A+AVD).
Oncology Learning Network – Treating Newly-Diagnosed Hodgkin Lymphoma – October 22, 2019
Andrew Evens, DO, MSc, FACP, Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey, Medical Director, RWJBarnabas Health, New Brunswick, recaps his presentation from the ASH Annual Hematologic Malignancies Conference where he spoke about how he treats newly‑diagnosed, classical Hodgkin lymphoma.
NJTV News – Stem cell recipient and donor meet to celebrate gift of life – September 30, 2019
Robert Wood Johnson University Hospital New Brunswick played host to a special reunion when 67-year-old New Jersey grandmother Lael McGrath met the 21-year-old German woman who served as her stem cell donor. McGrath was treated by Dr. Vimal Patel of the Blood and Marrow transplant program at Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, and was joined by members of her treatment team at the event.
ABC 7 Eyewitness News – New Jersey grandmother meets stem cell donor from around the world – September 27, 2019
A young German woman’s life-saving choice to become a bone marrow donor and the expertise of the Blood and Marrow Transplant (BMT) Program at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital New Brunswick – an RWJBarnabas Health facility – are helping a 67-year old New Jersey grandmother get back on track. The pair met for the first time during a special event with members of the BMT program, which is one of only two in the state, and the only one that is part of a National Cancer Institute-designated Comprehensive Cancer Center.
MedPage Today – Immunotherapy vs BRAF/MEK Inhibitors in the Adjuvant Setting for Melanoma – August 30, 2019
Dr. Janice Mehnert, Director, Regional Phase I Clinical Program at Rutgers Cancer Institute, spoke with MedPage Today at ASCO's annual meeting about immune checkpoint and BRAF/MEK therapy for patients, and the continuing importance of clinical trials to determine the best treatment options for patients.
NJ 101.5 FM Radio – Rutgers Cancer Institute puts focus on childhood cancer survivors – July 8, 2019
Rutgers Cancer Institute of New Jersey's LITE Program, for Long-Term, Information, Treatment Effects and Evaluation, recently held its annual Survivor's Family Education Night. This year's focus was addressing areas where knowledge may be deficient for survivors, which included questions on stress, depression, and post-traumatic stress after treatment.
NJTV News – NJ hospital provides targeted radiation therapy, reducing side effects – June 17, 2019
Rutgers Cancer Institute radiation oncologist Dr. Rahul R. Parikh, who is also the medical director of the Laurie Proton Therapy Center at Robert Wood Johnson University Hospital, speaks to NJTV about the benefits of proton therapy and common misconceptions about the treatment.
Cancer Network – Dr. Janice M. Mehnert on Immunotherapy vs BRAF/MEK Inhibitors in the Adjuvant Setting for Melanoma – June 13, 2019
Dr. Janice M. Mehnert, Director, Phase I and Investigational Therapeutics Program at Rutgers Cancer Institute, spoke with Cancer Network at ASCO about immune checkpoint and BRAF/MEK therapy for patients, and the continuing importance of clinical trials to determine the best treatment options for patients.
NJTV News – Cancer pavilion in New Brunswick will focus on clinical trials – June 3, 2019
Healthcare and government leaders across New Jersey convened for the announcement that Rutgers Cancer Institute, in partnership with RWJBarnabas Health, are launching a new, state-of-the-art cancer pavilion with the goal of combining research and treatment to address the needs of the 50,000 people diagnosed with cancer in New Jersey and the region.
NJTV – 'In Your Neighborhood' – May 22, 2019
Dr. Howard Hochster, Associate Director for Clinical Research spoke to NJTV recently about the promise of immunotherapy and the trials being done at Rutgers Cancer Institute to advance knowledge around newly developed cancer drugs.
iHeart Radio – 'CEO Unplugged' – April 24, 2019
Rutgers Cancer Institute Director Dr. Steven Libutti appears on the iHeart Radio program ‘CEO Unplugged’ to discuss the latest research advancements, cutting-edge treatments and a nurse navigator program at New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center and how it works in partnership with RWJBarnabas Health to deliver integrated cancer care.
NJTV News/PBS – Rutgers Cancer Institute recognized as a national powerhouse – April 23, 2019
Director Dr. Steven Libutti speaks to NJTV about Rutgers Cancer Institute’s redesignation as a Comprehensive Cancer Center, one of only 50 in the country and the only such center in New Jersey, and what the grant means for the Institute’s research and care of patients.
NJTV Online – Colorectal diagnoses on the rise among younger people – March 19, 2019
Emily Carey, Screen NJ coordinator and Rutgers Cancer Institute Cancer Health Equity Coordinator discusses CRC in the giant inflatable colon in this NJTV piece.
NJ 101.5 FM Radio – Rutgers cancer study cites improved survival rate with combo treatment – January 3, 2019
New research from Rutgers Cancer Institute investigators shows improved overall survival for pediatric Hodgkin lymphoma patients when treated with combined modality treatment.
M. Michele Blackwood, MD, discusses recent study results concerning the ideal frequency for breast cancer screenings.
Lymphoma Australia – HoLISTIC Hodgkin Lymphoma International Study – December 7, 2019
Andrew Evens, DO, MSc, FACP, Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey, Medical Director, RWJBarnabas Health, New Brunswick, spoke with Donna Gairns, National Lymphoma Nurse Manager from Lymphoma Australia at ASH 2019, Orlando, Florida.
OncologyTube – Management of Small Renal Masses – December 5, 2019
Eric A. Singer, MD, MA, MS, FACS discusses the management of small renal masses at the Kidney Cancer Association's 18th International Kidney Cancer Symposium in Miami, Florida.
Targeted Oncology – Brentuximab Vedotin Adds Benefit to A+AVD Therapy in cHL – December 3, 2019
Andrew M. Evens, DO, MSc, director of the Lymphoma Program and associate director for Clinical Services at the Rutgers Cancer Institute of New Jersey, discusses the significance of the results from the phase III ECHELON-1 trial in which patients with stage III/IV classical Hodgkin lymphoma (cHL) were treated with the combination of brentuximab vedotin (Adcetris) plus doxorubicin, vinblastine, and dacarbazine (A+AVD).
Oncology Learning Network – Treating Newly-Diagnosed Hodgkin Lymphoma – October 22, 2019
Andrew Evens, DO, MSc, FACP, Associate Director for Clinical Services, Rutgers Cancer Institute of New Jersey, Medical Director, RWJBarnabas Health, New Brunswick, recaps his presentation from the ASH Annual Hematologic Malignancies Conference where he spoke about how he treats newly‑diagnosed, classical Hodgkin lymphoma.
NJTV News – Stem cell recipient and donor meet to celebrate gift of life – September 30, 2019
Robert Wood Johnson University Hospital New Brunswick played host to a special reunion when 67-year-old New Jersey grandmother Lael McGrath met the 21-year-old German woman who served as her stem cell donor. McGrath was treated by Dr. Vimal Patel of the Blood and Marrow transplant program at Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, and was joined by members of her treatment team at the event.
ABC 7 Eyewitness News – New Jersey grandmother meets stem cell donor from around the world – September 27, 2019
A young German woman’s life-saving choice to become a bone marrow donor and the expertise of the Blood and Marrow Transplant (BMT) Program at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital New Brunswick – an RWJBarnabas Health facility – are helping a 67-year old New Jersey grandmother get back on track. The pair met for the first time during a special event with members of the BMT program, which is one of only two in the state, and the only one that is part of a National Cancer Institute-designated Comprehensive Cancer Center.
MedPage Today – Immunotherapy vs BRAF/MEK Inhibitors in the Adjuvant Setting for Melanoma – August 30, 2019
Dr. Janice Mehnert, Director, Regional Phase I Clinical Program at Rutgers Cancer Institute, spoke with MedPage Today at ASCO's annual meeting about immune checkpoint and BRAF/MEK therapy for patients, and the continuing importance of clinical trials to determine the best treatment options for patients.
NJ 101.5 FM Radio – Rutgers Cancer Institute puts focus on childhood cancer survivors – July 8, 2019
Rutgers Cancer Institute of New Jersey's LITE Program, for Long-Term, Information, Treatment Effects and Evaluation, recently held its annual Survivor's Family Education Night. This year's focus was addressing areas where knowledge may be deficient for survivors, which included questions on stress, depression, and post-traumatic stress after treatment.
NJTV News – NJ hospital provides targeted radiation therapy, reducing side effects – June 17, 2019
Rutgers Cancer Institute radiation oncologist Dr. Rahul R. Parikh, who is also the medical director of the Laurie Proton Therapy Center at Robert Wood Johnson University Hospital, speaks to NJTV about the benefits of proton therapy and common misconceptions about the treatment.
Cancer Network – Dr. Janice M. Mehnert on Immunotherapy vs BRAF/MEK Inhibitors in the Adjuvant Setting for Melanoma – June 13, 2019
Dr. Janice M. Mehnert, Director, Phase I and Investigational Therapeutics Program at Rutgers Cancer Institute, spoke with Cancer Network at ASCO about immune checkpoint and BRAF/MEK therapy for patients, and the continuing importance of clinical trials to determine the best treatment options for patients.
NJTV News – Cancer pavilion in New Brunswick will focus on clinical trials – June 3, 2019
Healthcare and government leaders across New Jersey convened for the announcement that Rutgers Cancer Institute, in partnership with RWJBarnabas Health, are launching a new, state-of-the-art cancer pavilion with the goal of combining research and treatment to address the needs of the 50,000 people diagnosed with cancer in New Jersey and the region.
NJTV – 'In Your Neighborhood' – May 22, 2019
Dr. Howard Hochster, Associate Director for Clinical Research spoke to NJTV recently about the promise of immunotherapy and the trials being done at Rutgers Cancer Institute to advance knowledge around newly developed cancer drugs.
iHeart Radio – 'CEO Unplugged' – April 24, 2019
Rutgers Cancer Institute Director Dr. Steven Libutti appears on the iHeart Radio program ‘CEO Unplugged’ to discuss the latest research advancements, cutting-edge treatments and a nurse navigator program at New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center and how it works in partnership with RWJBarnabas Health to deliver integrated cancer care.
NJTV News/PBS – Rutgers Cancer Institute recognized as a national powerhouse – April 23, 2019
Director Dr. Steven Libutti speaks to NJTV about Rutgers Cancer Institute’s redesignation as a Comprehensive Cancer Center, one of only 50 in the country and the only such center in New Jersey, and what the grant means for the Institute’s research and care of patients.
NJTV Online – Colorectal diagnoses on the rise among younger people – March 19, 2019
Emily Carey, Screen NJ coordinator and Rutgers Cancer Institute Cancer Health Equity Coordinator discusses CRC in the giant inflatable colon in this NJTV piece.
NJ 101.5 FM Radio – Rutgers cancer study cites improved survival rate with combo treatment – January 3, 2019
New research from Rutgers Cancer Institute investigators shows improved overall survival for pediatric Hodgkin lymphoma patients when treated with combined modality treatment.
CureToday.com – Nutrition Is Essential Through the Cancer Journey – December 12, 2018
Rutgers Cancer Institute's RDs Tracy Meissner and Lori Magoulas discuss the importance of nutrition in the cancer journey ahead of a nutrition workshop held at Rutgers Cancer Institute.
News 12 New Jersey – 10-minute cancer test? Australian scientists say they have it – December 5, 2018 s
Rutgers Cancer Institute's Dr. Shridar Ganesan weighs in on the science behind work by Australian researchers published in Nature Communications that could lead to a 10-minute cancer test.
CancerTherapyAdvisor.com – CD20xCD3 Bispecific Antibody REGN1979 in B-cell Non-Hodgkin Lymphoma – December 1, 2018
Dr. Rajat Bannerji discusses latest Ph1 trial results of REGN1979 for lymphomas at annual ASH meeting in San Diego, CA.
News 12 New Jersey – New cancer drug ‘Vitrakvi’ targets genetic mutations – December 5, 2018
Rutgers Cancer Institute's Drs. Howard Hochster and Shridar Ganesan provide reaction on the FDA’s approval of a new cancer drug that targets a mutation rather than tumor type.
Rutgers Cancer Institute's RDs Tracy Meissner and Lori Magoulas discuss the importance of nutrition in the cancer journey ahead of a nutrition workshop held at Rutgers Cancer Institute.
News 12 New Jersey – 10-minute cancer test? Australian scientists say they have it – December 5, 2018 s
Rutgers Cancer Institute's Dr. Shridar Ganesan weighs in on the science behind work by Australian researchers published in Nature Communications that could lead to a 10-minute cancer test.
CancerTherapyAdvisor.com – CD20xCD3 Bispecific Antibody REGN1979 in B-cell Non-Hodgkin Lymphoma – December 1, 2018
Dr. Rajat Bannerji discusses latest Ph1 trial results of REGN1979 for lymphomas at annual ASH meeting in San Diego, CA.
News 12 New Jersey – New cancer drug ‘Vitrakvi’ targets genetic mutations – December 5, 2018
Rutgers Cancer Institute's Drs. Howard Hochster and Shridar Ganesan provide reaction on the FDA’s approval of a new cancer drug that targets a mutation rather than tumor type.
News 12 New Jersey, NewJersey.News12.com – June 15, 2017
Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair products.
WPIX TV Channel 11, PIX11.com – June 15, 2017
Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair products.
WCTC 1450 AM – ‘Jersey Central’ with host Bert Baron – May 2, 2017
Rutgers Cancer Institute of New Jersey Chief Medical Officer Dr. Deborah Toppmeyer and genetic counselor Hetal Vig, who are both part of the Stacy Goldstein Breast Cancer Center and LIFE Center at the Institute, discuss the topic of hereditary cancers.
Spotlight on Middlesex County – April 2017
Rutgers Cancer Institute of New Jersey’s Dr. Darren Carpizo, director of the Liver Cancer and Bile Duct Oncology Program and a member of the Gastrointestinal/Hepatabiliary Oncology Program, gives a tour of his lab to Middlesex County Freeholder Director Ronald Rios, and discusses pancreatic research being conducted there. He also talks about the need for additional research dollars and a cancer walk sponsored by the county that supports pancreatic cancer research at Rutgers Cancer Institute.
NJTV – News with Mary Alice Williams – January 18, 2017
Rutgers Cancer Institute of New Jersey Director Dr. Steven Libutti discusses advances in cancer research and patient care at New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center.
Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair products.
WPIX TV Channel 11, PIX11.com – June 15, 2017
Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair products.
WCTC 1450 AM – ‘Jersey Central’ with host Bert Baron – May 2, 2017
Rutgers Cancer Institute of New Jersey Chief Medical Officer Dr. Deborah Toppmeyer and genetic counselor Hetal Vig, who are both part of the Stacy Goldstein Breast Cancer Center and LIFE Center at the Institute, discuss the topic of hereditary cancers.
Spotlight on Middlesex County – April 2017
Rutgers Cancer Institute of New Jersey’s Dr. Darren Carpizo, director of the Liver Cancer and Bile Duct Oncology Program and a member of the Gastrointestinal/Hepatabiliary Oncology Program, gives a tour of his lab to Middlesex County Freeholder Director Ronald Rios, and discusses pancreatic research being conducted there. He also talks about the need for additional research dollars and a cancer walk sponsored by the county that supports pancreatic cancer research at Rutgers Cancer Institute.
NJTV – News with Mary Alice Williams – January 18, 2017
Rutgers Cancer Institute of New Jersey Director Dr. Steven Libutti discusses advances in cancer research and patient care at New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center.
NJTV - Research: Law to Prevent Kids from Tanning Ineffective – August 2, 2016
Rutgers Cancer Institute of New Jersey behavioral scientists Dr. Elliot Coups and Dr. Jerod Stapleton discuss the findings of a study including the Rutgers School of Public Health that examined indoor tanning rates among children under 17 years of age before and after a 2013 ban on this practice by this age group.
WABC 770 AM – Dr. Arthur Perry Show – June 4, 2016
As the summer season gets underway, Rutgers Cancer Institute of New Jersey behavioral scientist Elliot Coups, PhD, discusses risks associated with too much sun exposure and developing skin cancer, as well as tips to help prevent this disease.
Rutgers Cancer Institute of New Jersey behavioral scientists Dr. Elliot Coups and Dr. Jerod Stapleton discuss the findings of a study including the Rutgers School of Public Health that examined indoor tanning rates among children under 17 years of age before and after a 2013 ban on this practice by this age group.
WABC 770 AM – Dr. Arthur Perry Show – June 4, 2016
As the summer season gets underway, Rutgers Cancer Institute of New Jersey behavioral scientist Elliot Coups, PhD, discusses risks associated with too much sun exposure and developing skin cancer, as well as tips to help prevent this disease.
WCTC 1450 AM – ‘Jersey Central’ with host Bert Baron – March 17, 2015
In recognition of the public health campaign “Kick Butts” that encourages young people to give up smoking, Dr. Michael Steinberg, director of the Rutgers Tobacco Dependence Program shared the benefits of quitting and how to get started.
Today Show, NBC – March 10, 2015
The Today Show highlights the Hugs for Brady Foundation and its efforts to bring its ‘Brady Buggy’ wagons to Rutgers Cancer Institute of New Jersey and our Flagship Hospital Robert Wood Johnson University Hospital.
In recognition of the public health campaign “Kick Butts” that encourages young people to give up smoking, Dr. Michael Steinberg, director of the Rutgers Tobacco Dependence Program shared the benefits of quitting and how to get started.
Today Show, NBC – March 10, 2015
The Today Show highlights the Hugs for Brady Foundation and its efforts to bring its ‘Brady Buggy’ wagons to Rutgers Cancer Institute of New Jersey and our Flagship Hospital Robert Wood Johnson University Hospital.
New Jersey 101.5 FM Radio – October 1, 2012
Rutgers Cancer Institute Chief Medical Officer Deborah L. Toppmeyer, MD, director of Rutgers Cancer Institute's Stacy Goldstein Breast Cancer Center and LIFE Center at Rutgers Cancer Institute, and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, describes the importance of mammograms
Spotlight on Middlesex County – June 2012
Rutgers Cancer Institute's Deputy Director Dr. Edmund Lattime and Co-Director of Rutgers Cancer Institute's Gastrointestinal-Hepatobiliary Oncology Program Dr. Elizabeth Poplin discuss a unique clinical trial at Rutgers Cancer Institute that utilizes vaccine therapy to treat pancreatic cancer. They also discuss the need to fund such study and share details about an annual pancreatic cancer walk that benefits pancreatic cancer research at Rutgers Cancer Institute.
WBGO 88.3 FM News – May 21, 2012
Rutgers Cancer Institute behavioral scientist, Elliot J. Coups, PhD, associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, describes the low skin cancer screening rates for U.S. Hispanics and the need to develop further interventions for this population.
WCTC 1450 AM – ‘New Jersey Today’ with host Bert Baron – April 10, 2012
Rutgers Cancer Institute Deputy Director Edmund Lattime, PhD, professor of surgery at UMDNJ-Robert Wood Johnson Medical School, discusses the science behind a vaccine treatment being studied at Rutgers Cancer Institute that is showing encouraging results in some pancreatic cancer patients.
WCBS 880 AM – A ‘Promising Lead’ in Fight Against Pancreatic Cancer - April 4, 2012
Early results from a clinical trial at Rutgers Cancer Institute show stable disease in pancreatic cancer for certain candidates following vaccine treatment. Elizabeth Poplin, MD, co-director of Rutgers Cancer Institute's Gastrointestinal-Hepatobiliary Oncology Program and professor of medicine at UMDNJ-Robert Wood Johnson Medical School, discusses the results presented at the American Association for Cancer Research Annual Meeting.
New Jersey 101.5 FM – Are Tanning Beds to Blame? - April 3, 2012
Jerod Stapleton, PhD, behavioral scientist at Rutgers Cancer Institute and assistant professor of medicine at UMDNJ-Robert Wood Johnson Medical School, weighs in on a study suggesting that tanning beds may contribute to a rise in women under 40 being diagnosed with melanoma.
What's Your Wrinkle: Mammograms - January 21, 2012
Laurie J. Kirstein, MD, FACS, breast surgical oncologist at Rutgers Cancer Institute and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School, made a guest appearance on the "What's Your Wrinkle" program on WOR 710 AM radio. She discussed the importance of mammograms, when to start a regular screening routine and who is a candidate for breast MRI with show host Arthur Perry, MD, FACS.
Rutgers Cancer Institute Chief Medical Officer Deborah L. Toppmeyer, MD, director of Rutgers Cancer Institute's Stacy Goldstein Breast Cancer Center and LIFE Center at Rutgers Cancer Institute, and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, describes the importance of mammograms
Spotlight on Middlesex County – June 2012
Rutgers Cancer Institute's Deputy Director Dr. Edmund Lattime and Co-Director of Rutgers Cancer Institute's Gastrointestinal-Hepatobiliary Oncology Program Dr. Elizabeth Poplin discuss a unique clinical trial at Rutgers Cancer Institute that utilizes vaccine therapy to treat pancreatic cancer. They also discuss the need to fund such study and share details about an annual pancreatic cancer walk that benefits pancreatic cancer research at Rutgers Cancer Institute.
WBGO 88.3 FM News – May 21, 2012
Rutgers Cancer Institute behavioral scientist, Elliot J. Coups, PhD, associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, describes the low skin cancer screening rates for U.S. Hispanics and the need to develop further interventions for this population.
WCTC 1450 AM – ‘New Jersey Today’ with host Bert Baron – April 10, 2012
Rutgers Cancer Institute Deputy Director Edmund Lattime, PhD, professor of surgery at UMDNJ-Robert Wood Johnson Medical School, discusses the science behind a vaccine treatment being studied at Rutgers Cancer Institute that is showing encouraging results in some pancreatic cancer patients.
WCBS 880 AM – A ‘Promising Lead’ in Fight Against Pancreatic Cancer - April 4, 2012
Early results from a clinical trial at Rutgers Cancer Institute show stable disease in pancreatic cancer for certain candidates following vaccine treatment. Elizabeth Poplin, MD, co-director of Rutgers Cancer Institute's Gastrointestinal-Hepatobiliary Oncology Program and professor of medicine at UMDNJ-Robert Wood Johnson Medical School, discusses the results presented at the American Association for Cancer Research Annual Meeting.
New Jersey 101.5 FM – Are Tanning Beds to Blame? - April 3, 2012
Jerod Stapleton, PhD, behavioral scientist at Rutgers Cancer Institute and assistant professor of medicine at UMDNJ-Robert Wood Johnson Medical School, weighs in on a study suggesting that tanning beds may contribute to a rise in women under 40 being diagnosed with melanoma.
What's Your Wrinkle: Mammograms - January 21, 2012
Laurie J. Kirstein, MD, FACS, breast surgical oncologist at Rutgers Cancer Institute and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School, made a guest appearance on the "What's Your Wrinkle" program on WOR 710 AM radio. She discussed the importance of mammograms, when to start a regular screening routine and who is a candidate for breast MRI with show host Arthur Perry, MD, FACS.
NJTV - New Pancreatic Study May Offer Hope for the Future - November 17, 2011
Rutgers Cancer Institute Deputy Director Dr. Edmund Lattime and Co-Director of Rutgers Cancer Institute's Gastrointestinal-Hepatobiliary Oncology Program Dr. Elizabeth Poplin discuss early results to a unique clinical trial that uses vaccine therapy to target pancreatic cancer.
The Rutgers Cancer Institute Cancer Education Series on EBC Radio features Rutgers Cancer Institute subject experts on a variety of topics.
Rutgers Cancer Institute Deputy Director Dr. Edmund Lattime and Co-Director of Rutgers Cancer Institute's Gastrointestinal-Hepatobiliary Oncology Program Dr. Elizabeth Poplin discuss early results to a unique clinical trial that uses vaccine therapy to target pancreatic cancer.
The Rutgers Cancer Institute Cancer Education Series on EBC Radio features Rutgers Cancer Institute subject experts on a variety of topics.
Click to download QuickTime
The Breeze Knows: Public Affairs Program - June 21, 2009
According to the American Cancer Society, prostate cancer is the most frequently diagnosed cancer in men. June is Prostate Cancer Awareness Month. In this Father's Day Edition of the Breeze Knows, Anita Velardo talks with Dr. Isaac Kim, Director of the Urologic Oncology Program at the Cancer Institute of New Jersey and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School. The Breeze 107.1 WWZY/ 99.7 WBHX www.breezeradio.com
One-on-One with Steve Adubato - October 17, 2008
Dr. Robert DiPaola, Director of The Cancer Institute of New Jersey, will be a guest on "One-on-One with Steve Adubato," airing Friday, October 17 at 5:30pm on CN8- The Comcast Network.
XM Satelite Radio - Reach MD Channel 157 - "Focus on Pharmacy" Segment - June 16, 2008
Susan Goodin, PharmD, FCCP, BCOP, director of pharmaceutical sciences at Rutgers Cancer Institute and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, discusses "Oral Chemotherapeutic Agents: How Have They Transformed Pharmacy and Oncology?"
The Breeze Knows: Public Affairs Program - June 21, 2009
According to the American Cancer Society, prostate cancer is the most frequently diagnosed cancer in men. June is Prostate Cancer Awareness Month. In this Father's Day Edition of the Breeze Knows, Anita Velardo talks with Dr. Isaac Kim, Director of the Urologic Oncology Program at the Cancer Institute of New Jersey and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School. The Breeze 107.1 WWZY/ 99.7 WBHX www.breezeradio.com
One-on-One with Steve Adubato - October 17, 2008
Dr. Robert DiPaola, Director of The Cancer Institute of New Jersey, will be a guest on "One-on-One with Steve Adubato," airing Friday, October 17 at 5:30pm on CN8- The Comcast Network.
XM Satelite Radio - Reach MD Channel 157 - "Focus on Pharmacy" Segment - June 16, 2008
Susan Goodin, PharmD, FCCP, BCOP, director of pharmaceutical sciences at Rutgers Cancer Institute and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, discusses "Oral Chemotherapeutic Agents: How Have They Transformed Pharmacy and Oncology?"